A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects

Clinical trial NCT02496221 · COMPLETED

Trial details

NCT number: NCT02496221
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2015-06-11
Primary completion: 2015-10-13
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.